PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7777184-0	1995	Differential effects of [3H]nemonapride and [3H]spiperone binding on human dopamine D4 receptors.	Spiperone	44-57	Rho GDP dissociation inhibitor beta	Homo sapiens	84-86	
8967990-5	1996	The maximum number of binding sites (Bmax) estimated using [125I]L-750,667 in hD4 HEK cells was 251 +/- 71 fmol/mg, which correlated well with the Bmax value determined using [3H]spiperone (227 +/- 83 fmol/mg) in the same membrane preparations.	Spiperone	179-188	Rho GDP dissociation inhibitor beta	Homo sapiens	78-81	
7777184-2	1995	Although both of the radioligands showed similar affinity constants for each hD4 receptor variant, the maximal number of binding sites labeled by [3H]nemonapride was approximately 1.35-fold higher than that by [3H]-spiperone for all variants.	Spiperone	215-224	Rho GDP dissociation inhibitor beta	Homo sapiens	77-80	
7777184-3	1995	Estimated Ki values for the inhibition of [3H]nemonapride binding by a series of dopaminergic ligands were highly correlated to respective values obtained for the inhibition of [3H]spiperone binding to each hD4 receptor.	Spiperone	181-190	Rho GDP dissociation inhibitor beta	Homo sapiens	207-210	
7777184-1	1995	We compared some binding parameters of [3H]nemonapride and [3H]spiperone in human dopamine D4 (hD4) receptors with three different numbers of tandem repeat units.	Spiperone	63-72	Rho GDP dissociation inhibitor beta	Homo sapiens	91-93